REGISTERED NUMBER: 05223275 (England and Wales)

Shil Pharmacy Limited

Unaudited Financial Statements

for the Period 1 September 2025 to 31 May 2026

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

3

Director:

Mrs S Desai

Registered office:

5th Floor Hodge House

114-116 St Mary Street

Cardiff

CF10 1DY

Registered number:

05223275 (England and Wales)

Accountants:

Menzies LLP, Statutory Auditors

5th Floor Hodge House

114-116 St Mary Street

Cardiff

CF10 1DY

Fixed assets

Intangible assets

4

-

-

Property, plant and equipment

5

9,430

50,436

9,430

50,436

Current assets

Inventories

30,204

30,204

Debtors

6

316,707

399,246

Cash at bank and in hand

33,956

184,535

380,867

613,985

Creditors

Amounts falling due within one year

7

(387,575

)

(407,889

)

Net current (liabilities)/assets

(6,708

)

206,096

Total assets less current liabilities

2,722

256,532

Provisions for liabilities

8

(2,358

)

(12,610

)

Net assets

364

243,922

Capital and reserves

Called up share capital

9

1

1

Retained earnings

363

243,921

Shareholders' funds

364

243,922

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 May 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 May 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 31 July 2026 and were signed by:

Mrs S Desai - Director

1.	Statutory information

Shil Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2004, is being amortised evenly over its estimated useful life of twenty years.

The director believes that the estimate useful life of the goodwill at the date of transition to FRS 102 (section 1A) was reliable.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Fixtures and fittings

-

15% on cost

Motor vehicles

-

25% on reducing balance

Inventories

Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments

Financial instruments are classified and accounted for according to the substance of the contractual arrangements as either financial assets, financial liabilities or equity instruments, and are held at amortised cost. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all its liabilities.

Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	Employees and directors

The average number of employees during the period was 9 (2025 - 13 ) .

4.	Intangible fixed assets

Goodwill

£

Cost

At 1 September 2025

and 31 May 2026

50,000

Amortisation

At 1 September 2025

and 31 May 2026

50,000

Net book value

At 31 May 2026

-

At 31 August 2025

-

5.	Property, plant and equipment

Fixtures

and

Motor

Computer

fittings

vehicles

equipment

Totals

£

£

£

£

Cost

At 1 September 2025

67,416

69,385

1,195

137,996

Disposals

-

(69,385

)

-

(69,385

)

At 31 May 2026

67,416

-

1,195

68,611

Depreciation

At 1 September 2025

56,890

30,356

314

87,560

Charge for period

1,843

-

134

1,977

Eliminated on disposal

-

(30,356

)

-

(30,356

)

At 31 May 2026

58,733

-

448

59,181

Net book value

At 31 May 2026

8,683

-

747

9,430

At 31 August 2025

10,526

39,029

881

50,436

6.

Debtors: amounts falling due within one year

2026

2025

£

£

Trade debtors

269,989

264,121

Other debtors

4,901

4,901

Directors' current accounts

21,000

112,446

Tax

1,880

-

VAT

18,937

16,266

Prepayments

-

1,512

316,707

399,246

7.

Creditors: amounts falling due within one year

2026

2025

£

£

Bank loans and overdrafts

-

367

Trade creditors

239,218

227,809

Tax

-

31,802

Social security and other taxes

2,344

2,074

Net wages

13,572

12,076

Pension

592

631

Accruals and deferred income

131,849

133,130

387,575

407,889

8.	Provisions for liabilities

2026

2025

£

£

Deferred tax

Accelerated capital allowances

2,358

12,610

Deferred

tax

£

Balance at 1 September 2025

12,610

Credit to Income Statement during period

(10,252

)

Balance at 31 May 2026

2,358

9.	Called up share capital

Allotted, issued and fully paid:

Number:

Class:

Nominal

2026

2025

value:

£

£

1

Ordinary

£1

1

1

10.	Transactions with directors

The following advances and credits to a director subsisted during the period ended 31 May 2026 and the year ended 31 August 2025:

2026

2025

£

£

Mrs S Desai

Balance outstanding at start of period

112,446

39,312

Amounts advanced

111,355

113,134

Amounts repaid

(202,801

)

(40,000

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of period

21,000

112,446

During the period Shil Pharmacy Limited paid rents of £13,500 (2025, year £18,000) to Mrs S Desai, director and sole shareholder of the company.